Secure platforms support for the N3C data enclave (covid-19)
Ended Awarded
- Contract number
- 75N95021F00001
- Awardee
-
Palantir Technologies Inc. UEI FSY4LVSBGWB7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,902,507
Award facts
- Opportunity
-
- 75N95021R00068 Solicitation number
- Contract value 100% obligated
- $7,902,507.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 511210 Software Publishers
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Denver, CO 80202, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
Palantir Technologies Inc. was awarded a $7.9 million firm fixed price delivery order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide secure platforms support for the N3C Data Enclave in support of COVID-19 efforts. The work will be performed over a five-month period ending in February 2022. No subcontractors or set aside designations were identified. The National Center for Advancing Translational Sciences is a part of the NIH focused on translational and clinical research, so this contract is likely to support data management and analytics capabilities to enable COVID-19 research through the N3C Data Enclave.
Quick answers
Who was awarded contract 75N95021F00001?
75N95021F00001 was awarded to Palantir Technologies Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2021.
How much is contract 75N95021F00001 worth?
The government has obligated $7,902,507 on 75N95021F00001.
Which agency awarded contract 75N95021F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95021F00001 an order under another contract?
Yes. 75N95021F00001 is a delivery order under 75N95021D00029, an indefinite delivery contract.
Was contract 75N95021F00001 competed?
The extent of competition for 75N95021F00001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award